Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $306 | $339 | $270 | $270 |
| - Cash | $104 | $104 | $115 | $103 |
| + Debt | $2 | $3 | $4 | $3 |
| Enterprise Value | $205 | $237 | $160 | $170 |
| Revenue | $40 | $35 | $45 | $36 |
| % Growth | 16.2% | -22.5% | 25% | – |
| Gross Profit | $25 | $21 | $25 | $22 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| EBITDA | $7 | $0 | $7 | $6 |
| % Margin | 16.2% | 0% | 16.2% | 15.9% |
| Net Income | $4 | $3 | $8 | $5 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS Diluted | 61.99 | 35.1 | 110.82 | 62.22 |
| % Growth | 76.6% | -68.3% | 78.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |